Companies by Subsector - Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| VAL | ValiRx | AIM | £1.98M | 0.16 | -2.20% | |
| OBD | Oxford BioDynamics | AIM | £4.72M | 0.11 | -4.00% | |
| VRCI | Verici Dx | AIM | £5.15M | 0.24 | -4.80% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| OPTI | OptiBiotix Health | AIM | £5.94M | 5.50 | -3.30% | |
| PRM | Proteome Sciences | AIM | £6.31M | 1.80 | 8.00% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| GDR | Genedrive | AIM | £16.06M | 1.05 | -1.60% | |
| IXI | Ixico | AIM | £17.44M | 7.50 | -1.50% | |
| EDEN | Eden Research | AIM | £20.49M | 2.51 | -2.40% | |
| IMM | ImmuPharma | AIM | £22.34M | 3.58 | -3.00% | |
| AREC | Arecor Therapeutics | AIM | £23.03M | 60.90 | -1.30% | |
| SBTX | SkinBioTherapeutics | AIM | £29.8M | 11.15 | -14.90% | |
| ABDX | Abingdon Health | AIM | £45.68M | 10.33 | 2.60% | |
| HVO | Hvivo | AIM | 2.70 | £50.84M | 7.40 | -5.10% |
| ANIC | Agronomics | AIM | £60.78M | 5.61 | -0.60% | |
| OBI | Ondine Biomedical Inc | AIM | £68.84M | 13.50 | 2.60% | |
| BVXP | Bioventix | AIM | 9.93 | £78.9M | 1,506.00 | -2.20% |
| 4BB | 4basebio | AIM | £81.58M | 519.75 | -0.40% | |
| FARN | Faron Pharmaceuticals OY | AIM | £94.23M | 42.30 | 1.10% | |
| ANP | Anpario | AIM | 2.36 | £107.22M | 529.00 | -0.90% |
| SCLP | Scancell Holdings | AIM | £118.19M | 9.75 | -1.10% | |
| DXRX | Diaceutics | AIM | £121.5M | 143.50 | -0.50% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BTG | BTG | AIM | 4.34 | £170.93M | 106.00 | -0.10% |
| PRTC | Puretech Health | FTSE Small Cap | £291.7M | 119.00 | -0.50% | |
| AVCT | Avacta Group | AIM | £311.49M | 66.50 | -7.00% | |
| GNS | Genus | FTSE 250 | 1.46 | £1.49B | 2,194.00 | -2.23% |